- Max Healthcare’s net income for the second quarter is 4.91 billion rupees, showing a 74% increase year-over-year.
- This net income figure surpasses the analysts’ estimate, which was 4.06 billion rupees.
- Revenue for the quarter is reported at 21.4 billion rupees, marking a 25% increase from the previous year.
- Despite the increase, revenue did not meet the estimated 25.37 billion rupees.
- Total costs for Max Healthcare rose to 17.2 billion rupees, which is a 26% increase compared to the previous year.
- The stock has a mixed outlook with 16 buy ratings, 4 hold ratings, and 5 sell ratings from analysts.
Max Healthcare Institute on Smartkarma
Analysts on Smartkarma are actively covering Max Healthcare Institute, providing valuable insights on the company’s prospects. Janaghan Jeyakumar, CFA, in their report “Quiddity NIFTY Sep25 Results: 13/14 Predictions Correct; Only One Surprise; ~US$1.2bn One-Way,” highlighted the upcoming index rebalancing events and expected flows. Brian Freitas, in the report “NIFTY50/NEXT50 Index Rebalance: Bunch Of (Mostly) Expected Changes; Positioning Increases,” noted the inclusion of Max Healthcare Institute in the NIFTY Index and the positioning dynamics following the changes.
As per Avien Pillay‘s bearish report “Max Healthcare (MAXHEALT IN): Sell,” concerns were raised over Max Healthcare’s high forward PE ratio and potential regulatory and competitive challenges. Despite this, the overall sentiment from analysts like Janaghan Jeyakumar and Brian Freitas leans towards a bullish outlook for Max Healthcare Institute, indicating optimism towards the company’s future performance in the healthcare sector.
A look at Max Healthcare Institute Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Max Healthcare Institute Limited, a prominent hospital chain in India, is positioned favorably for long-term growth and resilience according to Smartkarma Smart Scores. With a solid Growth score of 4 and a Resilience score of 4, the company is projected to expand its operations steadily while maintaining a stable position in the market.
Although Value and Dividend scores are moderate at 2 each, the company’s Momentum score of 3 suggests a positive direction in its market performance. Max Healthcare Institute‘s diverse range of services, including urology, oncology, orthopaedics, and more, highlights its commitment to providing comprehensive healthcare solutions to its patients across India.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
